Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-10-03

Clinical Trial Update: Oral Zinc Therapy for the Prevention of Mucositis [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial evaluating oral zinc therapy to prevent mucositis, and the study has completed. The sponsor is Sheba Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc sulfate (Zinc sulfate)

Snippet

Sponsor: Sheba Medical Center | Conditions: Mucositis | Phase 4 | Status: COMPLETED